Advertisement
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 3 to 7

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Moderna is charging $37 a dose for its experimental vaccine

Moderna Charging Much More for COVID-19 Vaccine Than Others

0
Vaccine currently in phase 3 trials; company confident it will be available by the end of the year
COVID-19 is associated with large vessel occlusion strokes

COVID-19 Tied to Higher Risk for Large Vessel Occlusion Strokes

0
However, no association seen between COVID-19 and small vessel occlusion stroke
For patients with severe COVID-19

Early Use of IL-6 Inhibitors May Improve COVID-19 Outcomes

0
Mortality, risk for intubation lower with IL6ri use in severe COVID-19 stage IIB versus stage III
The U.S. government will pay Johnson & Johnson $1 billion for 100 million doses of its vaccine if it is approved by the U.S. Food and Drug Administration

Johnson & Johnson Makes $1 Billion Vaccine Deal

0
Company has said it will offer doses at a not-for-profit cost to provide global access to the vaccine
As COVID-19 cases continue to surge across America

Scientists Call for Broader Use of Faster COVID-19 Tests

0
Currently, most tests rely on complex laboratory procedures, such as polymerase chain reaction
There are greater shortages of intensive care unit beds for critically ill patients in low-income neighborhoods compared with high-income neighborhoods

ICU Beds Lacking in Low-Income Neighborhoods Across the U.S.

0
Authors say policies facilitating hospital coordination urgently needed to mitigate the effects of COVID-19
Physicians say prior authorization continues to interfere with patient care and can lead to adverse clinical consequences

Health Plans Not Implementing Prior Authorization Reforms

0
Findings based on American Medical Association survey of practicing physicians' experiences
For patients with multiple myeloma and COVID-19

COVID-19 Case Fatality Rate 29 Percent in Multiple Myeloma Patients

0
Increased odds of adverse outcomes seen for Hispanic/Latinos, African-American Blacks versus white patients
Maryland-based Novavax said Tuesday that preliminary trials of an experimental COVID-19 vaccine were promising.

Experimental COVID-19 Vaccine Shows Encouraging Results

0
One study revealed that 56 people made high levels of antibodies with no adverse side effects